Publikationen, an denen er mitarbeitet LAURA MORENO GUTIÉRREZ (46)

2023

  1. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  2. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  3. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    Biomedicine and Pharmacotherapy, Vol. 164

2021

  1. Article serum micrornas as biomarkers of sepsis and resuscitation

    Applied Sciences (Switzerland), Vol. 11, Núm. 23

  2. Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential

    Frontiers in Physiology, Vol. 12

  3. Interleukin-6 and intrapulmonary shunt

    European Respiratory Journal

  4. Oxygen-sensitivity and pulmonary selectivity of vasodilators as potential drugs for pulmonary hypertension

    Antioxidants, Vol. 10, Núm. 2, pp. 1-14

  5. Restoration of vitamin d levels improves endothelial function and increases task-like k+ currents in pulmonary arterial hypertension associated with vitamin d deficiency

    Biomolecules, Vol. 11, Núm. 6

2020

  1. Total, bioavailable, and free vitamin D levels and their prognostic value in pulmonary arterial hypertension

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Ceramide and regulation of vascular tone

    International Journal of Molecular Sciences, Vol. 20, Núm. 2

  2. Reactive oxygen species as mediators of oxygen signaling during fetal-to-neonatal circulatory transition

    Free Radical Biology and Medicine, Vol. 142, pp. 82-96

  3. miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries

    Journal of Physiology, Vol. 597, Núm. 4, pp. 1185-1197

2014

  1. Ceramide mediates acute oxygen aensing in vascular tissues

    Antioxidants and Redox Signaling, Vol. 20, Núm. 1, pp. 1-14

  2. The flavonoid quercetin reverses pulmonary hypertension in rats

    PLoS ONE, Vol. 9, Núm. 12

  3. Upregulation of SK3 and IK1 channels contributes to the enhanced endothelial calcium signaling and the preserved coronary relaxation in obese Zucker rats

    PLoS ONE, Vol. 9, Núm. 10

2013

  1. Pulmonary vascular dysfunction induced by high tidal volume mechanical ventilation

    Critical Care Medicine, Vol. 41, Núm. 8

2012

  1. Different patterns of pulmonary vascular disease induced by type 1 diabetes and moderate hypoxia in rats

    Experimental Physiology, Vol. 97, Núm. 5, pp. 676-686

2011

  1. Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries

    American Journal of Physiology - Cell Physiology, Vol. 301, Núm. 1

  2. Lack of synergistic interaction between quercetin and catechin in systemic and pulmonary vascular smooth muscle

    British Journal of Nutrition, Vol. 105, Núm. 9, pp. 1287-1293

  3. Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction

    Journal of Cellular Physiology, Vol. 226, Núm. 10, pp. 2633-2640